Substantial Clinical Trials Market in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Substantial Clinical Trials Market in Mexico

Substantial Clinical Trials Market in Mexico – Clinical Trials in LATAM

Clinical trials play a pivotal role in advancing medical knowledge and improving healthcare outcomes. They are the essential stepping stones in bringing innovative treatments and therapies from the laboratory to the patient’s bedside.

Mexico, with its growing economy, diverse population, and robust healthcare infrastructure, has emerged as a significant player in the global clinical trials market. This blog delves into the substantial clinical trials market in Mexico, exploring its key features, benefits, challenges, and future prospects.

The Landscape of Clinical Trials in Mexico

Mexico’s clinical trials market has witnessed remarkable growth over the past few decades. Factors such as a large and diverse patient population, well-established medical infrastructure, and a growing pool of experienced healthcare professionals contribute to its attractiveness for clinical research. In recent years, the country has increasingly become a preferred destination for both domestic and international pharmaceutical and biotech companies seeking to conduct clinical trials.

Key Benefits of Conducting Clinical Trials in Mexico

  1. Diverse Patient Population: Mexico’s population is ethnically and genetically diverse, making it an ideal location for studies requiring varied genetic backgrounds. This diversity enhances the generalizability of research findings to broader populations.
  2. Lower Costs: Conducting clinical trials in Mexico often comes with lower costs compared to more developed countries. This cost advantage is attributed to factors such as lower labor costs, streamlined regulatory processes, and reduced expenses related to infrastructure.
  3. Efficient Regulatory Framework: Mexico’s regulatory authorities, such as the Federal Commission for Protection Against Health Risks (COFEPRIS), have made efforts to streamline the approval process for clinical trials. This allows for quicker initiation and completion of studies.
  4. Experienced Investigators: Mexico boasts a pool of skilled healthcare professionals and researchers who have experience in conducting clinical trials across various therapeutic areas.

Substantial Clinical Trials Market in Mexico

Substantial Clinical Trials Market in Mexico

Substantial Clinical Trials Market in Mexico

Challenges in the Clinical Trials Market

While Mexico offers numerous advantages for clinical trials, there are also challenges that need to be addressed:

  1. Regulatory Hurdles: Navigating the regulatory landscape can sometimes be complex, and differences in regulations between countries can lead to additional challenges for international trials.
  2. Infrastructure Disparities: While urban areas in Mexico have well-equipped medical facilities, rural regions may lack the necessary infrastructure for conducting trials. This can impact patient recruitment and access to healthcare.
  3. Language and Cultural Barriers: Effective communication with participants is crucial for the success of clinical trials. Language barriers and cultural differences can pose challenges in obtaining informed consent and ensuring participant compliance.
  4. Data Security and Quality: Ensuring data security and maintaining high-quality trial data is essential for the credibility of clinical research. Adequate measures need to be in place to address these concerns.

Future Prospects and Opportunities

The future of the clinical trials market in Mexico holds promise and potential for growth. As the country continues to invest in healthcare infrastructure, regulatory processes, and medical education, it is likely to attract more industry-sponsored trials and collaborations. Furthermore, Mexico’s increasing participation in global research networks and initiatives enhances its visibility and credibility on the international stage.

To fully realize its potential, Mexico must address the challenges it faces. Strengthening the regulatory framework, improving healthcare access in underserved areas, and investing in professional training are steps that can further enhance the clinical trials environment.


Mexico’s clinical trials market is on a steady rise, with its advantageous features and unique offerings making it an attractive destination for both domestic and international researchers. The nation’s diverse population, cost efficiency, experienced investigators, and improving regulatory framework contribute to its growth in the global clinical research landscape.

While challenges exist, they are not insurmountable, and with concerted efforts, Mexico can solidify its position as a substantial player in the field of clinical trials. As the country continues to evolve and adapt, its contributions to medical advancements are bound to become even more significant in the years to come.

Substantial Clinical Trials Market in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Substantial Clinical Trials Market in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Substantial Clinical Trials Market in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Substantial Clinical Trials Market in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Substantial Clinical Trials Market in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Substantial Clinical Trials Market in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Substantial Clinical Trials Market in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Substantial Clinical Trials Market in Mexico

The Cohortias Team

Substantial Clinical Trials Market in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Substantial Clinical Trials Market in Mexico

Network & Partnerships